Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Xali Gold Advises that Starcore has joined the Team to Develop the El Oro Tailings Project in Mexico
-
REE Automotive’s P7-C Electric Trucks and Platforms Approved for $30,000 Incentive Per Vehicle in Massachusetts
-
Limekiln Wind Farm: Boralex achieves major milestone, closes its first project financing in the UK
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
-
ChampionX Declares Quarterly Dividend
-
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
-
United Lithium adds Highly Prospective Kannus Reservation in Western Finland, and Commences Marketing Campaign
-
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
-
OMNI-LITE INDUSTRIES REPORTS FIRST QUARTER FISCAL 2024 RESULTS
-
Kandi Technologies Reports First Quarter 2024 Financial Results
-
Aduro Clean Technologies Provides Results on Testing of Hard to Recycle Crosslinked Polymers
-
First Wave BioPharma Changes Name to Entero Therapeutics
-
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
-
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
-
Multi Ways Holdings Reports Robust Financial Performance in Fiscal Year 2023 Results
-
SweetWater Brewing Launches New Sunset Sippin’ Cocktail Inspired Hard Seltzers
-
Superprof, World’s Largest Tutoring Network, Signs Up 100,000 American Students in Record Time
-
Plug Signs 3 GW BEDP Contract with Allied Green Ammonia for Electrolyzer Project in Australia
-
Uber Freight Advances Vision for Industry-Wide Procurement Platform with Uber Freight Exchange: Spot
-
Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
-
Signing Day Sports Achieves 334% Year-Over-Year Revenue Growth for First Quarter of 2024
-
CrossFirst Bankshares, Inc. Named to 2024 KBW Bank Honor Roll
-
RockTree Capital Unveils Cyberpunk Crypto Future In New Website
-
OpGen Announced 1-for-10 Reverse Stock Split
-
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
-
GXO Welcomes New Jewelry Customer Ring Concierge
-
Annual general meeting in IDEX Biometrics held on 16 May 2024
-
Signify completes share repurchase program to cover performance share plans
-
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
-
Man Group PLC : Form 8.3 - Tyman plc
-
Endeavour Silver Highlights Progress on its Three-Year Sustainability Strategy in 2023 Sustainability Report
-
Empowering Investors: BNRY Token Redefines Crypto Engagement with an Innovative Staking Solution
-
Liquidity Services Announces Participation in Upcoming Investor Conferences
-
BLAST HOGE Spearheads New DeFi Initiatives on the Blast Network, Expanding and Rewarding the Hoge Finance Community
-
The Board of Director's decision to issue convertible loans
-
Kering: Monthly statement on the total number of shares and voting rights (May 2024)
-
ISG Announces Launch of Socrates.AI to Support Next Generation of Claims Management
-
Alchip Technologies Reports Record Q1 FY2024 Revenue and Net Income
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
-
South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in Scientific Reports
-
JD.com Announces First Quarter 2024 Results
-
Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2024
-
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
-
LANZATECH ALERT: Bragar Eagel & Squire, P.C. Investigates De-SPAC Merger of LNZA and AMCI and Encourages Investors to Contact the Firm
-
SHIMMICK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shimmick Corporation on Behalf of Shimmick Stockholders and Encourages Investors to Contact the Firm
-
INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Inotiv Stockholders and Encourages Investors to Contact the Firm
-
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. is Investigating FutureFuel Corp. on Behalf of FutureFuel Stockholders and Encourages Investors to Contact the Firm
-
Macerich Announces Initial Progress in its Path Forward Strategic Plan

